Article
Apolipoprotein E in lipid metabolism and neurodegenerative disease.
Trends in endocrinology and metabolism: TEM - 1 Aug 2023
Yang Linda G, March Zachary M, Stephenson Roxan A, Narayan Priyanka S
Abstract excerpt
Dysregulation of lipid metabolism has emerged as a central component of many neurodegenerative diseases. Variants of the lipid transport protein, apolipoprotein E (APOE), modulate risk and resilience in several neurodegenerative diseases including late-onset Alzheimer's disease (LOAD). Allelic variants of the gene, APOE, alter the lipid metabolism of cells and tissues and have been broadly associated with several...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
